Esplugues de Llobregat, Spain

Cedric Gobber

This inventor holds 1 USPTO granted patent. Top assignee: Leuko Labs, Inc. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cedric Gobber. Retrieved from https://idiyas.com/inventor/cedric-gobber-39dmpsik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Cedric Gobber

Introduction

Cedric Gobber, a talented inventor based in Esplugues de Llobregat, Spain, has made significant contributions to the field of medical technology. With a focus on non-invasive solutions, Gobber is committed to advancing health monitoring systems, particularly for white blood cells.

Latest Patents

Gobber holds a patent for a non-invasive white blood cell monitoring device. This innovative invention aims to improve patient care by providing a more efficient and less intrusive method for monitoring white blood cell counts, which are critical in understanding and managing various medical conditions.

Career Highlights

Cedric currently works at Leuko Labs, Inc., where he collaborates with a dedicated team to further the development of groundbreaking medical technologies. His expertise and vision have positioned him as a notable figure in the realm of healthcare innovations.

Collaborations

Throughout his career, Gobber has worked alongside esteemed colleagues such as Ian Butterworth and Carlos Castro-Gonzalez. These collaborations have enabled him to share ideas and insights, fostering an environment of creativity and innovation within the team.

Conclusion

Cedric Gobber's work exemplifies the spirit of innovation that drives advancements in medical technology. With his patent and contributions to Leuko Labs, Inc., he is paving the way for more effective healthcare solutions that could transform patient monitoring and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…